Company intelligence / Profile preview

Ronovo Surgical

Shanghai/Xuhui District, Shanghai, Chinaronovosurgical.com ↗

Ownership: Private
Employees: ~140
Development stage: Commercial

Overview

The Carina™ Platform has received regulatory approval in China and initial clinical studies have demonstrated feasibility and safety for soft tissue procedures such as urology. The company continues to expand its clinical footprint and international partnerships.

Therapeutic areas: Other
Modalities: DeviceDigital surgery platformRobotic-assisted surgery system
Industry: Surgical Medical Devices

Drug pipeline

1 asset

Carina Platform

Commercial

Indications: Minimally invasive surgery, Laparoscopic surgery

Partnerships

International partnerships with surgical community and technology companies are being developed; specific partners not named publicly as of June 2025.

Beyond the preview

Go deeper on Ronovo Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ronovo Surgical.

Explore the full profile